Categories: All postsSoftware

CGI Group’s stock is too expensive right now, says this portfolio manager

Kim Bolton
CGI Group (CGI Group Stock Quote, Chart TSX:GIB.A) got hit by the tech selloff that closed out 2018 but the stock is now back to its old chart-climbing ways, hitting new highs since early February. That pace makes it tough for investors to jump in, says Kim Bolton, president and portfolio manager of Black Swan Dexteritas, who spoke to BNN Bloomberg about the stock.

“We don’t own CGI but we have in the past,” Bolton told BNN Bloomberg Monday. “This is in the consulting services sector and there are a number of significant players. The ones in North America that always come to mind and are always on the RFPs are CGI and Accenture.”

“Accenture has done a fabulous job in keeping the ball rolling,” he says. “They bought [OCTO Technology], a French company, about three years ago and they were able to expand their footprint over through Europe.”

“CGI is a little bit expensive at this stage. If you can actually get it down in the low $70.00s that’s where we’d like to buy,” he says.

Since the end of October, CGI has gained 17.7 per cent, rising from a low of $75.54 to $88.95 as of late-day trading on Tuesday.

CGI and Accenture have both provided excellent returns in recent years. Since January 2014, CGI’s share price has gone up 154 per cent, while Accenture is up 101 per cent over the same period.

CGI last reported its earnings on January 30, where its first quarter fiscal 2019 arrived in line with analysts’ estimates. The company reported revenue of $2.96 billion, a 5.2 per cent year-over-year increase, and Adjusted EBIT of $439.2 million, a 7.5 per cent year-over-year increase.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: gib.a
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

4 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

4 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

4 days ago